Document is current
Any future updates will be listed below
-
Authors
Alvarez-Peregrina, Cristina http://orcid.org/0000-0003-1097-4581
Sanchez-Tena, Miguel Angel http://orcid.org/0000-0002-2583-1789
Martinez-Perez, Clara http://orcid.org/0000-0002-0996-5007
Villa-Collar, Cesar http://orcid.org/0000-0002-6743-8264
,
Montero-Torrejon, Alejandro
Lopez-Muñoz, Alfredo
Ruiz-Hernandez, Alicia
Gonzalez-Abad, Ana Isabel
Santos-de-Melo, Antonio Manuel
de Corcuera Terrero, Beatriz
Gargallo-Martinez, Beatriz
Mataix-Palao, Carolina
Boeck-Maier, Christina
Celdran-Vivancos, Diego Asensio
Rodriguez, Isabel
Vega-Dominguez, Javier
Martinho-Antunes, João Manuel
Garay-Dominguez, Jose Carlos
Recalde-Zurita, Jose Ignacio
Reina-Gallego, Juan Luis
Rocha, Laura
Lérida, Manuel
Gonzalez-Perez, Mariano
Silva-Carrola, Patricia
Alves-Silva, Paula
Gutierrez-Ortega, Ramon
Blanco-Cotovio, Raquel
Maia, Raul Manuel
Wahl, Siegfried
Kratzer, Timo
Oliveira-Hipólito, Vladimiro
Ohlendorf, Arne http://orcid.org/0000-0002-6373-1420
-
Funding
Funding for this research was provided by:
Carl Zeiss Vision
- License Information
-
More Information
Article History
Received: 29 June 2023
Accepted: 2 October 2023
First Online: 17 October 2023
Declarations
:
: The study has been approved by the Medical Ethics Research Committee of Hospital Clínico San Carlos, Madrid, Spain (approval number 22/384-EC_P). The study has been also registered in the EU Clinical Trials Register on 27 April 2022 (EudraCT: 2022–001696) and in ClinicalTrials.gov (ID NCT05919654), published on 26 June 2023: .Written, informed consent to participate will be obtained from all the parents, and an additional informed consent will be signed by the participants older than 12 years old.
: Not applicable.All the data from the participants will be anonymized for publication.
: The authors declare that they have no competing interests.
